BioForce Nanosciences HoldingsBFNH -0.59%34 3-Year ROIIC % is 0.60 as of Dec. 2025, which is 37% below its 10-year median of 0.95. GuruFocus rates BFNH with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 1,830 Consumer Packaged Goods companies, BioForce Nanosciences Holdings ranks worse than 54.92% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
BioForce Nanosciences Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 0.60%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
BioForce Nanosciences Holdings 3-Year ROIIC % Related Terms
BioForce Nanosciences Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BFNH vs LSF, GWLL, HAIN: 3-Year ROIIC % Comparison
For the Packaged Foods subindustry, BioForce Nanosciences Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioForce Nanosciences Holdings 3-Year ROIIC % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where BioForce Nanosciences Holdings's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -0.49 (Dec. 2025) - -0.486 (Dec. 2022) )
/
( 0.506 (Dec. 2025) - 1.174 (Dec. 2022) )
=
-0.004
/
-0.668
=
0.60%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
BioForce Nanosciences Holdings (BFNH) has a 3-Year ROIIC % of 0.60 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BioForce Nanosciences Holdings and its competitors. This is 37% below median its historical median of 0.95. According to the industry distribution chart, BioForce Nanosciences Holdings ranks #1005 out of 1830 companies in the Consumer Packaged Goods industry, placing it in the top 54.9%.
Is BioForce Nanosciences Holdings' 3-Year ROIIC % too high?
BioForce Nanosciences Holdings' current 3-Year ROIIC % of 0.60 is 37% below median its 10-year median of 0.95. The Consumer Packaged Goods industry median 3-Year ROIIC % is 2.89. BioForce Nanosciences Holdings' value of 0.60 is 79.2% below this industry median. Based on the distribution chart, BioForce Nanosciences Holdings ranks #1005 out of 1830 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, BioForce Nanosciences Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does BioForce Nanosciences Holdings' 3-Year ROIIC % compare to LSF and GWLL?
According to the Consumer Packaged Goods industry distribution chart, BioForce Nanosciences Holdings ranks #1005 out of 1830 companies for 3-Year ROIIC %. This places BioForce Nanosciences Holdings in the lower half of its industry. The industry median 3-Year ROIIC % is 2.89. BioForce Nanosciences Holdings' value of 0.60 is 79.2% below this benchmark. While the company's 10-year median is 0.95 vs. the industry median of 2.89, BioForce Nanosciences Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Consumer Packaged Goods company?
The median 3-Year ROIIC % among Consumer Packaged Goods companies is 2.89, based on 1,830 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioForce Nanosciences Holdings's current 3-Year ROIIC % of 0.60 is 79.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on BioForce Nanosciences Holdings and its competitors. For the Consumer Packaged Goods industry, the median 3-Year ROIIC % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioForce Nanosciences Holdings's current 3-Year ROIIC % is 0.60, which is 37% below median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioForce Nanosciences Holdings stock overvalued right now?
BioForce Nanosciences Holdings (BFNH) has a current 3-Year ROIIC % of 0.60. The current 3-Year ROIIC % is 0.60, which is 37% below median its 10-year median of 0.95 and 79.2% below the Consumer Packaged Goods industry median of 2.89. BioForce Nanosciences Holdings' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For BioForce Nanosciences Holdings (BFNH), the current 3-Year ROIIC % is 0.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioForce Nanosciences Holdings Business Description
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
34GF Score
Get the complete analysis for BFNH
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFNH has been successfully added to your 
